Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

NCT06413121 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1557

Enrollment

INDUSTRY

Sponsor class

Conditions

Diptheria Immunization
Tetanus Immunization
Pertussis Immunization
Hepatitis B Immunization
Haemophilus Influenzae Type B Immunization
Polio Immunization

Interventions

BIOLOGICAL: Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Reduced Dose IPV
BIOLOGICAL: Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV

Sponsor

Serum Institute of India Pvt. Ltd.